Citation: | The Establishment of Immunoradiometric Assay for CA15-3 in Human Serum[J]. Journal of Isotopes, 2004, 17(2): 74-74. |
[1] |
AbeM,KufeDW.IdentificationofaFamilyofHighMolecularWeightTumor-associatedGlyco-proteins[J].JImmunol,1987,139:257~261.
|
[2] |
HayesDF,ZurawskiVR,KufeDW,etal.Com-parisonofCirculatingCA15-3andCarcinoembry-onicAntigenLevelsinPatientsWithBreastCan-cer[J].JClinOncol,1986,4:1542~1550.
|
[3] |
严桂风.CEA、CA19-9、CA125、CA15-3联合检测用于恶性肿瘤诊断[J].临床检验杂志,1998,16(6):373~374.
|
[4] |
PereyL,HayesDF,MaimonisP,etal.TumorSelectiveReactivityofaMonoclonalAntibodyPreparedAgainstARecombinantPeptideDerivedFromtheDF3HumanBreastCarcinoma-associat-edAntigen[J].CancerResearch,1992,52(1):2563~2568.
|
[5] |
BaeckstromD,NilssonO,PriceMR,etal.Dis-criminationofMUC1MucinsFromOtherSialyl-lea-carryingGlyco-proteinsbyColonCarcinomaCellsUsingaNovelMonoclonalAntibody[J].CancerRes,1993,53:755~759.
|
[6] |
陈智周,范振符,扬剑,等.肿瘤标志物CA15-3的免疫放射分析及其临床应用[J].中华肿瘤杂志,1998,20(2):125~127.
|
[7] |
王玉肖,燕强奋,于洁.抗TSH单克隆抗体的碘标记及其在免疫放射分析中的应用[J].同位素,1993,6(4):203~207.
|
[8] |
BjernerJ,NorumLF,NilssonO,etal.MUC1SerumAssaysinBreastCancer:TumorSpecifici-tiesandReferenceLevels[J].TumorBiol,2002,23:315~323.
|